Selective decline in cellular immune response to varicella-zoster in the elderly.
about
Varicella-zoster virusVaccination against Herpes Zoster and Postherpetic NeuralgiaHuman herpes viruses latent infection in the nervous systemLongitudinal study on oral shedding of herpes simplex virus 1 and varicella-zoster virus in individuals infected with HIVResistant pathogens, fungi, and viruses.Statistical analysis of pure tone audiometry and caloric test in herpes zoster oticusHerpes Zoster Infections in SLE in a University Hospital in Saudi Arabia: Risk Factors and OutcomesHigh incidence of herpes zoster in patients with systemic lupus erythematosus: an immunological analysis.Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccineVaricella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine.Concurrent reactivation of varicella zoster virus and herpes simplex virus in an immunocompetent child.IE63-specific T-cell responses associate with control of subclinical varicella zoster virus reactivation in individuals with malignancies.Virus vasculopathy and stroke: an under-recognized cause and treatment target.The significance of the determination of lymphocytes with clinical manifestation of ophthalmic zoster sine herpete.Asymptomatic reactivation and shed of infectious varicella zoster virus in astronauts.Disseminated cutaneous herpes zoster in an immunocompetent elderly patientHerpes zoster incidence in a multicenter cohort of solid organ transplant recipientsPharmacologic management of herpes zoster and postherpetic neuralgia.Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years.Pathogenesis of varicelloviruses in primatesRace and stress in the incidence of herpes zoster in older adults.Varicella zoster disease of the central nervous system: epidemiological, clinical, and laboratory features 10 years after the introduction of the varicella vaccineHerpes Zoster Risk Reduction through Exposure to Chickenpox Patients: A Systematic Multidisciplinary ReviewMajor depressive disorder and immunity to varicella-zoster virus in the elderly.Herpes zoster ophthalmicus: disease spectrum in young adults.Influence of age and nature of primary infection on varicella-zoster virus-specific cell-mediated immune responsesThe epidemiology of varicella-zoster virus infections: a mathematical model.Simian varicella virus infection of Chinese rhesus macaques produces ganglionic infection in the absence of rash.Emerging therapies for herpes viral infections (types 1 - 8).Varicella-zoster virus-specific enzyme-linked immunospot assay responses and zoster-associated pain in herpes zoster subjectsIncidences of Herpes Zoster and Postherpetic Neuralgia in Japanese Adults Aged 50 Years and Older From a Community-based Prospective Cohort Study: The SHEZ Study.Effector and Central Memory Poly-Functional CD4(+) and CD8(+) T Cells are Boosted upon ZOSTAVAX(®) VaccinationChronic medical conditions as risk factors for herpes zoster.Molecular studies of Varicella zoster virus.Prevention of shingles by varicella zoster virus vaccination.Prevention of shingles: safety and efficacy of live zoster vaccine.Incidence of herpes zoster ophthalmicus: results from the Pacific Ocular Inflammation Study.Herpesvirus infections of the nervous system.Specific lysis of varicella zoster virus-infected B lymphoblasts by human T cells.Null cell senescence and its potential significance to the immunobiology of aging
P2860
Q24683811-C646F6EC-15B3-4016-8DEF-422D6A238604Q28276808-14232680-2272-4C40-976D-BB4B6D2BADB7Q28297488-617B9088-7E2D-4FEB-A5CE-9DF5C368A1F9Q28660303-D8CEE777-89EB-454A-89D6-D64E59A8CFAAQ30301237-9E0BD559-3FEB-42E5-B581-4FA2A9833B50Q30489729-A6CCC6F8-A871-49E6-AEBF-7E4DBF0B7D8BQ33393264-B2BEAAC0-1C0F-4331-8447-69D965B4C1E2Q33562897-65481578-E3E2-4373-99D9-49187A20A752Q33585318-C4AC47FE-08F0-4A6D-A4FE-868987258FFAQ33585349-F608D975-EA62-47D5-B5D9-7A2730140FCAQ33631768-0351AEF2-DAB5-43DB-9559-0D00CDF35644Q33723698-FEEF1149-0A8E-4582-8BF3-4E2CD79A1564Q34015853-86641480-BE23-48C5-BEF6-61610D73CA8DQ34043330-5D0310F9-475B-45D8-A383-22856CAE5079Q34124505-F9AF1AFB-F943-4B80-B1DF-452A5358F409Q34259163-B8740754-7CB0-46B3-8C46-6E5EA8797439Q34293248-4AE810A5-4F20-459C-A526-9CC52EA526B1Q34322115-553E0489-A09F-4D14-98B0-0C881F96911EQ34635527-850EA759-1D7F-4DD3-82AB-50F2A64FE2C6Q34714480-326C11E3-C4E3-4546-90A1-D00B8FA356D4Q34750739-3CBDCBB1-252F-46D2-9993-47055944BF31Q34763836-16F08129-DA4C-4850-BF55-F3C27BA924FFQ34785366-8ECED7E0-D021-40C8-BAF3-75E77C402033Q34842227-BF42F90D-8F97-4454-8372-E6DC14698679Q35057623-F56B0173-693D-47CE-B085-332797CF4B99Q35105463-97769B5F-860D-4D09-9156-F58312CF7B65Q35228926-D535EDD9-3039-4866-A55A-3DF7344D5725Q35886301-368AEAC7-4C88-459D-8422-C8FE57E0E879Q35967376-DD3915B2-245C-4680-9F2C-B563C7112B5BQ36191676-32AF1762-CB0F-4BE3-A66C-84619D5E9E25Q36225734-6D18AB9A-D9CF-4F52-A692-5C2EA888A2C3Q36237622-E9075CB2-7AD3-4A3C-89B8-8A93F10F9A26Q36512861-9F3AC7BE-E636-45EC-A294-0DC5FCB7A376Q36515070-42BBFD72-8647-4B01-9D06-DF4E7CE8FC3AQ36600317-22340A32-06E7-4485-9FE9-BB208F46FBC8Q36642986-0D6C099A-6A11-4083-BFA2-15411F271986Q36674803-D544F678-3BBB-4BD3-964F-9F1556111319Q36728589-9E3D4E67-5082-4C6D-AEE1-0DB45BADFD9EQ36861230-92E77811-EC16-4E7C-8B78-B14A9729D7D1Q36985583-2B5BFE04-CF9A-4497-8D78-2F5CC116D9FB
P2860
Selective decline in cellular immune response to varicella-zoster in the elderly.
description
1980 nî lūn-bûn
@nan
1980年の論文
@ja
1980年学术文章
@wuu
1980年学术文章
@zh-cn
1980年学术文章
@zh-hans
1980年学术文章
@zh-my
1980年学术文章
@zh-sg
1980年學術文章
@yue
1980年學術文章
@zh
1980年學術文章
@zh-hant
name
Selective decline in cellular immune response to varicella-zoster in the elderly.
@en
type
label
Selective decline in cellular immune response to varicella-zoster in the elderly.
@en
prefLabel
Selective decline in cellular immune response to varicella-zoster in the elderly.
@en
P356
P1433
P1476
Selective decline in cellular immune response to varicella-zoster in the elderly.
@en
P2093
P304
P356
10.1212/WNL.30.6.582
P407
P577
1980-06-01T00:00:00Z